Table 1.
n (%) or mean [range] | |
---|---|
Tumoral involvement (N = 86) | |
Skin | 73* (84.9) |
Lymph nodes | 48 (55.8) |
Spleen | 19 (22) |
Liver | 15 (17.4) |
Cerebrospinal fluid | 4 (4.5) |
Eye | 3 (3.5) |
Complete blood count (n = 79) | |
White blood cells, ×109/L | 1 [0.8-53.8] |
Neutrophils | 2.7 [0.02-10] |
Eosinophils | 0.2 [0-4.1] |
Basophils | 0.02 [0-0.2] |
Lymphocytes | 2.1 [0.3-9.3] |
Monocytes | 0.5 [0-3] |
Myelemia | 0.1 [0-1.6] |
Blasts | 5.4 [0-45] |
Hemoglobin, g/dL | 11.2 [6.5-18.4] |
Platelets, ×109/L | 106 [13-302] |
Bone marrow aspirates (n = 73), % | |
Blasts† | 64.0 [0-100] |
Neutrophil line | 17.0 [0-66] |
Eosinophils line | 0.8 [0-21] |
Basophils line | 0.1 [0-3] |
Erythroblasts | 10.0 [0-50] |
Lymphocytes and plasma cells | 8.0 [0-48] |
Monocytes | 1.4 [0-9] |
Blast morphologies, %‡ | |
Vacuoles only | 26/21 |
Pseudopodia and vacuoles | 68/17 |
Undifferentiated morphology | 65/7 |
Lymphoid-like morphology | 18/68 |
Monocytoid-like morphology | 17/6 |
Blasts with granulations | 17/3 |
Including 40 cases with a single cutaneous lesion.
Percentage of total bone marrow cells.
Number of cases presenting these characteristics/mean proportion of blast cells presenting this morphology.